Paper · 40206366
Investigating the Lethal Effects of Carvone on the Protoscoleces of Hydatid Cyst, In Vitro and Ex Vivo.
Mahmoudvand H and 5 others. Iran J Parasitol, 2025. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Investigating the Lethal Effects of Carvone on the Protoscoleces of Hydatid Cyst, In Vitro and Ex Vivo. Papers, record 40206366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40206366
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Investigating the Lethal Effects of Carvone on the Protoscoleces of Hydatid Cyst, In Vitro and Ex Vivo.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,999,510 | Carvone and its pharmacological activities: A systematic review. | Phytochemistry | 2022 | https://conductscience.org/library/papers/34999510 | PubMed |
| 2 | 31,349,828 | Efficacy and safety of Curcuma longa essential oil to inactivate hydatid cyst protoscoleces. | BMC Complement Altern Med | 2019 | https://conductscience.org/library/papers/31349828 | PubMed |
| 3 | 19,350,321 | Management of cystic echinococcosis complications and dissemination: where is the evidence? | World J Surg | 2009 | https://conductscience.org/library/papers/19350321 | PubMed |
| 4 | 24,244,154 | DNA damage repair and bacterial pathogens. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/24244154 | PubMed |
| 5 | 24,003,211 | DNA damage sensing by the ATM and ATR kinases. | Cold Spring Harb Perspect Biol | 2013 | https://conductscience.org/library/papers/24003211 | PubMed |
| 6 | 33,048,959 | A systematic review of medicinal plants used against Echinococcus granulosus. | PLoS One | 2020 | https://conductscience.org/library/papers/33048959 | PubMed |
| 7 | 33,482,425 | Combination of synthetic anthelmintics and monoterpenes: Assessment of efficacy, and ultrastructural and biophysical properties of Haemonchus contortus using atomic force microscopy. | Vet Parasitol | 2021 | https://conductscience.org/library/papers/33482425 | PubMed |
| 8 | 24,868,323 | Cystic echinococcosis of the liver: A primer for hepatologists. | World J Hepatol | 2014 | https://conductscience.org/library/papers/24868323 | PubMed |
| 9 | 28,509,873 | Leishmanicidal Activity and Structure-Activity Relationships of Essential Oil Constituents. | Molecules | 2017 | https://conductscience.org/library/papers/28509873 | PubMed |
| 10 | 34,097,889 | In vitro effects of harmine against Echinococcus granulosus protoscoleces by stimulating DNA damage. | Exp Parasitol | 2021 | https://conductscience.org/library/papers/34097889 | PubMed |
1 to 10 of 21
See all 21 referencesCited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,738,766 | Molecular Targets and Biological Activities of Carvone: An Evidence-Graded Review. | Molecules | 2026 | https://conductscience.org/library/papers/42738766 | PubMed |
| 42,598,428 | Synergistic Effects of Combined Caryophyllene and Albendazole against Invaginated and Evaginated Protoscoleces of Echinococcus granulosus. | Iran J Parasitol | 2026 | https://conductscience.org/library/papers/42598428 | PubMed |
| 41,824,136 | Green Synthesized Zinc Oxide Nanoparticles as a Promising Adjuvant to Albendazole in the Management of Hydatid Cyst Disease: Molecular and Biochemical Insights. | Acta Parasitol | 2026 | https://conductscience.org/library/papers/41824136 | PubMed |
| 41,670,898 | Inhibition of Antioxidant Genes Expression in Echinococcus Granulosus by Baicalein: Implications for Novel Antiparasitic Strategies. | Acta Parasitol | 2026 | https://conductscience.org/library/papers/41670898 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40206366
GET https://conductscience.org/api/papers/v1/40206366/references?page=2